Literature DB >> 33661364

Visual outcomes after small incision lenticule extraction and implantable collamer lens V4c for moderate myopia: 1-year results.

Aruma Aruma1,2,3, Meiyan Li1,2,3, Joanne Choi4, Huamao Miao1,2,3, Ruoyan Wei1,2,3, Danjuan Yang1,2,3, Peijun Yao1,2,3, Ling Sun1,2,3, Xiaoying Wang1,2,3, Xingtao Zhou5,6,7.   

Abstract

PURPOSE: To compare 1-year visual outcomes after implantable collamer lens V4c (EVO-ICL) implantation and small incision lenticule extraction (SMILE) for moderate myopia.
METHODS: In this retrospective study, 67 eyes of 39 patients with a preoperative manifest refraction spherical equivalent between - 3.00 and - 6.00 diopters (D) were selected from a database of SMILE and ICL implantation procedures performed from April 2018 to December 2018. Thirty-two eyes of 20 patients underwent EVO-ICL implantation, and 35 eyes of 19 patients underwent SMILE. At the routine 1-year follow-up appointment, all selected patients were examined for higher-order ocular aberrations, retinal image quality, and a quality of vision (QoV) questionnaire. This data was then analyzed.
RESULTS: No complications were observed. Uncorrected and corrected visual acuities at 1 year after surgery were - 0.13 ± 0.07 and - 0.15 ± 0.06 logMAR in the SMILE group, and - 0.10 ± 0.07 and - 0.16 ± 0.05 logMAR in the ICL group. Twenty-nine eyes (90.6%) which underwent ICL implantation and 34 eyes (97.1%) which underwent SMILE were within ± 0.5 D of the attempted spherical equivalent (P = 0.49). Changes in coma after ICL were significantly less than after SMILE (P = 0.002). The leading complaints after ICL and SMILE were halos (84.4%) and blurred vision (65.7%), respectively.
CONCLUSIONS: Both SMILE and ICL implantation provided good safety, efficacy, and predictability in correcting moderate myopia. The subjective visual complaints consisted mainly of halos after ICL and starbursts and blurred vision after SMILE.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Implantable collamer lens V4c; Moderate myopia; Small incision lenticule extraction; Visual quality

Year:  2021        PMID: 33661364     DOI: 10.1007/s00417-020-04982-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  2 in total

1.  Evaluation of visual quality of spherical and aspherical intraocular lenses by Optical Quality Analysis System.

Authors:  Yan Chen; Xue Wang; Chuan-Di Zhou; Qiang Wu
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

2.  Two-Year Outcomes of Visian Implantable Collamer Lens with a Central Hole for Correcting High Myopia.

Authors:  Zhipeng Yan; Huamao Miao; Feng Zhao; Xiaoying Wang; Xun Chen; Meiyan Li; Xingtao Zhou
Journal:  J Ophthalmol       Date:  2018-07-03       Impact factor: 1.909

  2 in total
  4 in total

1.  Evaluation of morphological features: femtosecond-LASIK flap vs. SMILE cap, and the effects on corneal higher-order aberrations.

Authors:  Xiaoying He; Qin He; Minjie Yuan; Zhi Fang; Kai Zhang; Tiepei Zhu; Wei Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-27       Impact factor: 3.535

2.  Influence of Ocular Residual Astigmatism on the Correction of Myopic Astigmatism by Toric Implantable Collamer Lens: A Comparative Study With Femtosecond Laser Small Incision Lenticule Extraction.

Authors:  Ling Sun; Xiaoyu Zhang; Lan Ding; Yang Shen; Yishan Qian; Xingtao Zhou
Journal:  Front Med (Lausanne)       Date:  2022-06-13

Review 3.  In vivo optical quality of posterior-chamber phakic implantable collamer lenses with a central port.

Authors:  Robert Montés-Micó; Francisco Pastor-Pascual; Enrique Artiaga-Elordi; Ramón Ruiz-Mesa; Pedro Tañá-Rivero
Journal:  Eye Vis (Lond)       Date:  2021-08-16

4.  Two-Year Visual Outcomes of Evolution Implantable Collamer Lens and Small Incision Lenticule Extraction for the Correction of Low Myopia.

Authors:  Mengjun Fu; Meiyan Li; Yiyong Xian; Zhiqiang Yu; Haorun Zhang; Joanne Choi; Lingling Niu; Xiaoying Wang; Xingtao Zhou
Journal:  Front Med (Lausanne)       Date:  2022-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.